Microvolt T wave alternans in patients with hypertension and left ventricular hypertrophy

Journal of Human Hypertension

Volumn 15, Issue , 2001, Pages S95-S96

  Francis, D ^a   Lane, R ^a   Mayet, J ^a   Foale, R A ^a   Thom, S ^a   Peters, Nicholas ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Arrhythmia; Repolarisation; Sudden death

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BICYCLE ERGOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; FOURIER ANALYSIS; HEART ARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE HYPERTROPHY; HOLTER MONITORING; HUMAN; HYPERTENSION; LONG TERM CARE; OUTCOMES RESEARCH; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; T WAVE; TREATMENT OUTCOME;

ARRHYTHMIA; ELECTROCARDIOGRAPHY; EXERCISE TEST; FOURIER ANALYSIS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; VECTORCARDIOGRAPHY;

EID: 0034789086     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001254     Document Type: Article

References (6)

1. Barron HV. T-wave alternans and serious ventricular arrhythmias: a tale of two T-waves. J Am Coll Cardiol 2000; 36: 2254-2256.
2. Grimm W, Hoffmann J, Menz V, Maisch B. Relation between microvolt level T wave alternans and other potential noninvasive predictors of arrhythmic risk in the Marburg Cardiomyopathy Study. Pacing Clin Electrophysiol 2000; 23: 1960-1964.
3. Gold MR et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 2000; 36: 2247-2253.
4. Hennersdorf MG et al. T wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-moderate heart failure. Pacing Clin Electrophysiol 2000; 23: 1386-1391.
5. Kaufman ES et al. Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am J Physiol Heart Circ Physiol 2000; 279: H1248-H1255.
6. Momiyama Y et al. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy. Jpn Circ J 1997; 61: 650-656.